期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 9, 期 7, 页码 1667-1671出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0968-0896(01)00074-8
关键词
-
资金
- NCI NIH HHS [CA17625] Funding Source: Medline
- NIAID NIH HHS [AI33066] Funding Source: Medline
Ru(II)/Ru(III) polypyridyl complexes containing 2.6-(2'-benzimidazolyl)-pyridine or chalcone as co-ligands were synthesized and characterized proviously (Mishra, L.; Sinha, R. Indian J. Chem., Sec. A 2001, in press. Mishra. L.: Sinha, R. Indian J. Chem., Src. A, 39A, 2000, 1131). Their interaction with aqueous buffered calf thymus DNA was measured. (Novakova, O.; Kasparkova, J., Vrana, O.: van Vliet. P. M., Reedijk. J.; Brabec, V, Biochem. 34, 1995, 12369 and these results prompted additional screening for anti-HIV (human immunodeficiency virus) activity against DNA replication in H9 lymphocytes and cytotoxic activity against eight tumor cell lines. The most active compounds were 17 in the former assay (EC50 < 0.1 g/mL and TI > 23.1) and 3.8. 10, and 14 in the latter assay, especially selectively against the 1A9 ovarian cancer cell line (IC50 = 4.1, 3.8, 3.6, and 2.5 mug/mL. respectively). (C) 2001 Elsevier Science Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据